ArticleFrontiers in cell and developmental biology2026
Predictive value of ABVS and VTIQ parameters for axillary lymph node metastasis in breast cancer.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to investigate the predicting value of Automated Breast Volume Scanner (ABVS) combined with Virtual Touch Imaging and Quantification (VTIQ) for axillary lymph node (ALN) metastasis burden in patients with breast cancer. Methods: This study retrospectively included patients with breast cancer at the Third Affiliated Hospital of Guangzhou Medical University between June 2021 and August 2023. Patients were categorized into the low metastasis burden group (≤2 metastatic lymph nodes) and the high metastasis burden group (≥3 metastatic lymph nodes) based on ALN metastasis status. Image parameters were measured using two-dimensional ultrasound, ABVS, and VTIQ. Results: A total of 80 patients were included, with a mean age of 55.61 ± 11.10 years, comprising 43 individuals in the LMB group and 37 in the HMB group. The results of multivariate logistic regression analysis revealed that a maximum diameter (OR = 7.386, 95% CI: 1.140-47.845, P = 0.036), the lotus root sign (OR = 5.292, 95% CI: 1.073-26.107, P = 0.041), and mean shear wave velocity (OR = 1.956, 95% CI: 1.263-3.029, P = 0.003) were independent risk factors for high lymph node metastatic burden in the breast cancer patients. The AUC for the parameters of ABVS and VTIQ in predicting lymph node metastatic burden was 0.872 (95%CI: 0.754-0.950, P < 0.001), with the corresponding sensitivity and specificity of 73.0% and 90.7%, respectively. Conclusion: The combined utilization of parameters from ABVS and VTIQ might have promising predictive value for high ALN tumor burden in breast cancer patients. However, large-scale, multi-center, prospective studies are needed to further confirm our findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.